Back to resources

Thought Leadership Expertise

Straight From the Horse’s Mouth

ILAP: how might it affect the UK's positioning in cell and gene?

Katy and Don discuss recent regulatory patterns in cell and gene

Kim Benton on CMC Development and Readiness Pilot

In the absence (or presence) of a yellow brick road: a DHC round table discussion

In testing as in life, context is everything

Don Fink makes the case for a Conditional Use Authorization Pathway

Gene therapy is expensive. But so are misleading attacks.

Dark Horse guidance – what’s next?

Dark Horse to offer proposed FDA guidance on FTE capsid ratio